Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review

Journal Title: Neurology Letters - Year 2022, Vol 1, Issue 2

Abstract

Background: Cognitive dysfunction is a debilitating characteristic of multiple sclerosis (MS) that affects approximately 60% of patients. To date, the only effective treatments for cognitive decline are cognitive rehabilitation and exercise training. While previous studies reported the beneficial effect of antioxidants on MS patients, several other studies investigated the effect of antioxidant supplements on the cognitive performance of MS patients. We aimed to conduct a systematic review to examine whether there is an association between antioxidants supplements and cognitive performance in MS patients.Methods: We searched PubMed, Embase, Scopus, and Web of Science for the identification of relevant studies in November 2021. We included control trials, cohort, case-control, and cross-sectional studies which showed the effect of any type of antioxidants on cognitive performance in MS patients.Results: After screening 12 papers were included in our study. Our review included three studies that examined the effect of ginkgo Biloba on cognitive performance, two examined the Mediterranean diet, and remained studies each investigated the vitamin A, Omega 5, Omega 3, estriol, epigallocatechin-3-gallate (EGCG), Boswellia papyrifera, and paleolithic diet. Overall, it seems that there were no benefits of antioxidant administration on cognitive performance in MS patients.

Authors and Affiliations

Fardin Nabizadeh, Fatemeh Sodeifian, Ali Ghaderi, Amir Mohammad Sharafi, Mohammad Balabandian

Keywords

Related Articles

Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review

The first appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) named coronavirus disease 2019 (COVID-19) was reported from Wuhan in December 2019. While this virus displays several respiratory manif...

Helicobacter Pylori specific antibodies among multiple sclerosis patients

Background: Multiple sclerosis (MS) is one of the most common neurological diseases that occurs predominantly in young adults and more commonly in women. MS is a chronic inflammatory disease characterized by demyelinati...

Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke

Introduction: Stroke is the third most common cause of mortality and the most common disability disorder among adults. We aimed to study the relationship between Chlamydia pneumonia infection and non-cardio Ambulatory is...

Acute relapse of Multiple Sclerosis (MS) in an adolescent patient after Tuberculin skin test (TST): a case report

Activation of MS as a result of bacterial and viral infections is proposed by various studies. However, immune responses initiated by a bacterial antigen can rarely lead to the activation or occurrence of MS. Hereby, we...

Transient global amnesia associated with acute bacterial endocarditis; A case report

Introduction: Transient global amnesia (TGA) is a sudden loss of memory without definite etiology. Some cardiac conditions like myocardial infarction, mitral valve prolapse, takotsubo syndrome, and arrhythmias have been...

Download PDF file
  • EP ID EP711700
  • DOI 10.52547/NL.1.2.48
  • Views 69
  • Downloads 0

How To Cite

Fardin Nabizadeh, Fatemeh Sodeifian, Ali Ghaderi, Amir Mohammad Sharafi, Mohammad Balabandian (2022). Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review. Neurology Letters, 1(2), -. https://europub.co.uk/articles/-A-711700